0001104659-21-128007.txt : 20211020
0001104659-21-128007.hdr.sgml : 20211020
20211020140657
ACCESSION NUMBER: 0001104659-21-128007
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211020
DATE AS OF CHANGE: 20211020
EFFECTIVENESS DATE: 20211020
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Plato BioPharma, Inc.
CENTRAL INDEX KEY: 0001494188
IRS NUMBER: 271519734
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-417748
FILM NUMBER: 211333723
BUSINESS ADDRESS:
STREET 1: 7581 W. 103RD AVE. SUITE 300
CITY: WESTMINSTER
STATE: CO
ZIP: 80021
BUSINESS PHONE: 720-887-8628
MAIL ADDRESS:
STREET 1: 7581 W. 103RD AVE. SUITE 300
CITY: WESTMINSTER
STATE: CO
ZIP: 80021
D
1
primary_doc.xml
X0708
D
LIVE
0001494188
Plato BioPharma, Inc.
2701 KENT AVE
WEST LAFAYETTE
IN
INDIANA
47906-1382
3174634527
DELAWARE
None
None
Corporation
true
Robert
Leasure, Jr.
2701 Kent Ave
West Lafayette
IN
INDIANA
47906-1382
Executive Officer
Director
Beth
A.
Taylor
2701 Kent Ave
West Lafayette
IN
INDIANA
47906-1382
Executive Officer
Director
Other Health Care
Decline to Disclose
- 06b
false
2021-10-04
false
true
true
0
3000000
3000000
0
false
39
0
0
0
The securities were issued as consideration in an acquisition.
false
Plato BioPharma, Inc.
/s/ Beth A. Taylor
Beth A. Taylor
CFO Vice President Finance
2021-10-20